Cibi e Bevande
Publication of transparency notifications
Press release - regulated information
Publication of transparency notification s
(Article 14(1) of the Law of 2 May 2007 on the disclosure of large shareholders in issuers whose shares are admitted to trading on a regulated market)
Ghent, BELGIUM – 1 5 July 202 1 , 07 :00 CE S T – Biotalys (Euronext - BTLS) , an AgTech company focused on addressing food protection challenges to enable a more sustainable and safer food supply, announces today, in accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings in issuers whose shares are admitted to trading on a regulated market (the 'Belgian Transparency Act'), that it has received transparency notifications from Ackermans & van Haaren NV, Gimv NV, Adviesbeheer Gimv Venture Capital 2010 NV and Biotech Fonds Vlaanderen NV, Sofinnova Partners S.A.S., ParticipatieMaatschappij Vlaanderen NV, K&E BV, Biovest NV, Madeli participaties B.V. and Agri Investment Fund C.V.B.A.
1. Ackermans & van Haaren NV
Ackermans & van Haaren NV has announced that, on 2 July 2021, it held 4,016,281 shares of Biotalys NV, representing 13.38% of the total number of voting rights.
The notification dated 9 July 2021 contains the following information:
In accordance with article 11, §1 of the Act of 2 May 2007, stichting administratiekantoor “Het Torentje” acts in its own name and on behalf of the companies set forth under (ii) up to and including (vi).
2. Gimv NV ,
Adviesbeheer Gimv Venture Capital 2010 NV and Biotech Fonds Vlaanderen NV
Gimv NV, Adviesbeheer Gimv Venture Capital 2010 NV and Biotech Fonds Vlaanderen have announced that, on 2 July 2021, combined they held 4,307,393 shares of Biotalys NV, representing 14.35% of the total number of voting rights.
The notification dated 14 July 2021 contains the following information:
3. So finnova Partners S.A.S.
Sofinnova Partners S.A.S. has announced that, on 2 July 2021, it held 4,226,962 shares of Biotalys NV, representing 14.08% of the total number of voting rights.
The notification dated 9 July 2021 contains the following information:
4. P articipatieMaatschappij Vlaanderen NV
ParticipatieMaatschappij Vlaanderen NV has announced that, on 2 July 2021, it held 2,494,813 shares of Biotalys NV, representing 8.31% of the total number of voting rights.
The notification dated 14 July 2021 contains the following information:
5. K&E BV
K&E BV has announced that, on 2 July 2021, it held 1,867,837 shares of Biotalys NV, representing 6.22% of the total number of voting rights.
The notification dated 14 July 2021 contains the following information:
6. Biovest NV
Biovest NV has announced that, on 2 July 2021, it held 2,048,798 shares of Biotalys NV, representing 6.82% of the total number of voting rights.
The notification dated 14 July 2021 contains the following information:
7. Madeli participaties B . V .
Madeli participaties B.V. has announced that, on 2 July 2021, it held 1,948,798 shares of Biotalys NV, representing 6.49% of the total number of voting rights.
The notification dated 12 July 2021 contains the following information:
8. Agri Investment Fund C.V.B.A
Agri Investment Fund C.V.B.A. has announced that, on 2 July 2021, it held 2,158,708 shares of Biotalys NV, representing 7.19% of the total number of voting rights.
The notification dated 8 July 2021 contains the following information:
The respective transparency notifications can be found on www.biotalys.com/investors.
About Biotalys
Biotalys is an Agricultural Technology (AgTech) company focused on addressing food protection challenges with proprietary protein-based biocontrol solutions and aiming to provide alternatives to conventional chemical pesticides for a more sustainable and safer food supply. Based on its novel AGROBODY™ technology platform, Biotalys has developed a strong and diverse pipeline of effective products with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and was listed on Euronext Brussels on 2 July 2021. The company is based in the biotech cluster in Ghent, Belgium. More information can be found on www.biotalys.com.
For further information, please contact
Toon Musschoot, Strategic Communications Manager
T: +32 (0)9 274 54 00
E: Toon.Musschoot@biotalys.com
Consilium Strategic Communications
Amber Fennell, Chris Gardner, Chris Welsh
T: +44 (0)203 709 5700
E: Biotalys@consilium-comms.com
Attachment
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti